IGF1 and chronic kidney disease: Moreover, multivariate analysis including age, sex, BMI, chronic kidney disease, BNP and insulin use (Model 2) revealed that an elevated IGF-1/IGFBP-3 ratio was associated with a significantly decreased risk for CV death and 3P-MACE (Supplementary Table 5).